About Us

Honeywell's involvement in refrigerant production dates from the early 1950's since when ongoing investment has led to a global technology leadership position. Among many notable milestones, in more recent times the development and patenting of HFC-based Genetron® 507 and Genetron® 410A, in the early 90's, put Honeywell among the leaders in HCFC replacement technology.

In accordance with the Montreal Protocol, which recognised the adverse effects on the Earth's ozone layer caused by chlorine-containing fluorocarbon emissions, chlorofluorocarbons (CFCs) were phased-out in developed countries in 1995. Now the use of hydrochlorofluorocarbon (HCFC), also regulated by the international agreement, is progressively being reduced towards eventual phase-out within the European Union.

Having been at the forefront of developing alternatives for CFCs, Honeywell has also taken a leading role in finding replacements for HCFC refrigerants. This led to the introduction of Genetron® 507 and Genetron® 410A, which are non-ozone depleting and offer higher energy efficiency solutions than competitive replacement products.

Genetron® 507, an azeotropic 50/50 mixture of Genetron® 125 and Genetron® 143a, provides a long-term replacement for Genetron® 502 and Genetron® 22 in low and medium temperature commercial refrigeration applications. Genetron® 410A is a near-azeotropic 50/50 mixture of Genetron® 32 and Genetron® 125, and is a long-term replacement for Genetron® 22 in air-conditioning applications.

These breakthrough products have since become the benchmark standards for a large and growing number of refrigeration and air-conditioning OEMs worldwide, and complement Honeywell's refrigerants portfolio, one of the most extensive currently offered by any producer in the global marketplace.